Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cantel Medical Reports 53% Increase in Earnings Per Share From Continuing Operations On 156% Increase in Net Sales for Quarter Ended April 30, 2002.


Business Editors/Medical Writers

LITTLE FALLS Little Falls is the name of some places in the United States of America:
  • Little Falls, Minnesota
  • Little Falls, New Jersey
  • Little Falls (city), New York
  • Little Falls (town), New York
, N.J.--(BUSINESS WIRE)--May 30, 2002

EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format.  - Reflecting 3 for 2 Stock Split

$0.23 VS. $0.15 FOR QUARTER

$0.54 VS. $0.39 FOR NINE MONTHS

CANTEL MEDICAL CORP. (NYSE NYSE

See: New York Stock Exchange
:CMN CMN Common
CMN Children's Miracle Network (since 1983; Salt Lake City, Utah)
CMN Certificate of Medical Necessity
CMN Canadian Museum of Nature
CMN Community Mapping Network
CMN Common Information
) reported income from continuing operations continuing operations

Parts of a business that are expected to be maintained as an ongoing segment of an overall business operation. Income and losses from continuing operations are reported separately if any segments have been discontinued during the
 of $2,314,000 or $0.23 per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 share, an increase of 53% per share, on sales of $33,196,000 for its third quarter ended April 30, 2002, as compared with income from continuing operations of $1,141,000, or $0.15 per diluted share, on sales of $12,976,000 for the quarter ended April 30, 2001.

For the nine months ended April 30, 2002, the Company reported income from continuing operations of $5,177,000, or $0.54 per diluted share, an increase of 38% per share, on sales of $87,261,000, as compared with income from continuing operations of $2,778,000, or $0.39 per diluted share, on sales of $34,346,000 for the nine months ended April 30, 2001.

The results presented reflect a 3 for 2 stock split effected as a stock dividend of three shares for each two shares issued and outstanding, paid May 14, 2002 to the holders of Cantel's common stock as of the close of business on May 7, 2002.

For the quarter and the nine months ended April 30, 2001, the Company also reported income from discontinued operations Discontinued operations

Divisions of a business that have been sold or written off and that no longer are maintained by the business.
 of its consumer products business of $225,000, or $0.03 per diluted share.

The Company further reported that its balance sheet at April 30, 2002 showed continued improvement with current assets Current Assets

Appearing on a company's balance sheet, it represents cash, accounts receivable, inventory, marketable securities, prepaid expenses, and other assets that can be converted to cash within one year.
 of $55,818,000, including cash of $8,909,000, a current ratio of 3.1:1, a ratio of funded debt Funded Debt

Long-term debt that matures after more than one year.

Notes:
This is usually issued as a bond or a long-term note.
See also: Bond, Debt, Maturity, Note



Funded debt

Debt maturing after more than one year.
 to equity of .57 and stockholders' equity Stockholders' Equity

The portion of the balance sheet that includes capital received from investors in exchange for stock (paid-in capital), donated capital, and retained earnings. This is equal to total assets minus liabilities, preferred stock and intangible assets.
 of $54,771,000.

James P. Reilly, President and Chief Executive Officer of CANTEL, commented, "The Company's strong financial performance reflects the continuing successful integration of the Minntech acquisition and the related synergies being realized." Reilly continued, "The recent addition of two senior executives responsible for the Renal renal /re·nal/ (re´n'l) pertaining to the kidney.

re·nal
adj.
Of or in the region of the kidneys.


Renal
Relating to the kidney.
 and Filtration filtration: see sewerage; water supply.
Filtration

The separation of solid particles from a fluidsolids suspension of which they are a part by passage of most of the fluid through a septum or membrane that retains most of the solids
 Divisions of Minntech will enable us to further enhance the results of Minntech." In addition, he stated, "The recent 3 for 2 stock split and the listing of the Company's shares on the New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 should improve liquidity and stability of the Company's common stock."

Cantel Medical Corp., a healthcare company, is a leading provider of infection prevention and control products, specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 medical device reprocessing Reprocessing may refer to:
  • Nuclear reprocessing
  • Recycling
 systems and sterilants, diagnostic imaging and therapeutic medical equipment primarily focused on endoscopy endoscopy

Examination of the body's interior through an instrument inserted into a natural opening or an incision, usually as an outpatient procedure. Endoscopes include the upper gastrointestinal endoscope (for the esophagus, stomach, and duodenum), the colonoscope (for the
, hollow fiber membrane filtration and separation technologies for medical and non-medical applications, and scientific instrumentation instrumentation, in music: see orchestra and orchestration.
instrumentation

In technology, the development and use of precise measuring, analysis, and control equipment.
. The Company also provides technical maintenance services for their own products, as well as for certain competitors' products.

The Company will hold a conference call to discuss the results for the third quarter ended April 30, 2002 on Thursday, May 30, 2002 at 11:00 AM EST EST electroshock therapy.

EST
abbr.
electroshock therapy
. To participate in the conference call, dial 1-877-407-8035 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, May 30 at 1:00 PM through midnight on May 31, by dialing 1-877-660-6853 and using passcode #1618 and conference ID #36381. The call will be simultaneously broadcast live over the Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 on vcall.com at http://www.vcall.com/EventPage.asp?ID=81724. A replay of the webcast will be available on Vcall for 30 days.

For further information, visit the Cantel Web site at www.cantelmedical.com .

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. All forward-looking statements involve risks and uncertainties, including, without limitation, the risks detailed in the Company's filings and reports with the Securities and Exchange Commission. Such statements are only predictions, and actual events or results may differ materially from those projected.


                         CANTEL MEDICAL CORP.
              CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                 (In thousands, except per share data)

                               Three Months Ended    Nine Months Ended
                                    April 30,             April 30,
                               ------------------   -----------------
                                2002      2001(1)    2002      2001(1)
                                ----      -------    ----      ------

Net sales                    $ 33,196   $ 12,976   $ 87,261   $ 34,346

Cost of sales                  20,046      8,144     53,471     20,833
                             --------   --------   --------   --------

Gross profit                   13,150      4,832     33,790     13,513

Operating expenses:
 Selling                        3,991      1,410     10,395      4,128
 General and administrative     3,856      1,340     10,709      3,948
 Research and development       1,073        248      2,739        703
                             --------   --------   --------    -------
Total operating expenses        8,920      2,998     23,843      8,779
                             --------   --------   --------    -------

Income before interest and
 income taxes                   4,230      1,834      9,947      4,734

Interest expense (income) -
 net                              560         (1)     1,648        (14)
                             --------   --------   --------    -------

Income before income taxes      3,670      1,835      8,299      4,748

Income taxes                    1,356        694      3,122      1,970
                             --------   --------   --------    -------

Income from continuing
 operations                     2,314      1,141      5,177      2,778

Income from discontinued
 operations                         -        225          -        225
                             --------   --------   --------    -------

Net income                   $  2,314   $  1,366   $  5,177    $ 3,003
                             ========   ========   ========    =======

Diluted earnings per
 common share (2):
 Continuing operations       $   0.23   $   0.15   $   0.54    $  0.39
 Discontinued operations            -       0.03          -       0.03
                             --------   --------   --------    -------

Net income                   $   0.23   $   0.18   $   0.54    $  0.42
                             ========   ========   ========    =======

Weighted average shares -
 diluted (2)                    9,963      7,415      9,585      7,203

(1)   Restated from amounts previously reported to reflect warehouse
      and shipping expenses in cost of sales and related amounts
      billed to customers in net sales. These reclassifications had no
      effect on income.

(2)  Reflects a 3-for-2 stock split paid on May 14, 2002.


                         CANTEL MEDICAL CORP.
                 CONDENSED CONSOLIDATED BALANCE SHEETS
                            (In thousands)


                                                  April 30,   July 31,
                                                     2002       2001
                                                  ---------  ---------
   Assets
Current assets                                   $ 55,818     $ 26,494
Property and equipment, net                        22,987          844
Intangible assets                                   7,994          622
Goodwill                                           15,357          585
Other assets                                        7,536        3,384
                                                ---------     --------
                                                $ 109,692     $ 31,929
                                                =========     ========

   Liabilities and stockholders' equity
Current liabilities                             $  17,764     $  9,825
Long-term debt                                     28,500            -
Other long-term liabilities                         8,657           77
Stockholders' equity                               54,771       22,027
                                                ---------     --------
                                                $ 109,692     $ 31,929
                                                =========     ========
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 30, 2002
Words:984
Previous Article:1-800Wineshop And Wine Brats Form A Two-Year Strategic Partnership To Offer A Wine Brats Wine Club And In-Home Wine Tasting Events Nationwide.
Next Article:Kingnet Security to Distribute Network-1 Intrusion Prevention Solution in China.



Related Articles
Cantel Industries reports increased sales and earnings for the quarter and nine months ended April 30, 1997.
Minntech Reports First Quarter Results.
Cantel Medical Reports Record Results Income From Continuing Operations Increases 20% for Quarter and 47% for Year Ended July 31, 2001.
Cantel Medical Reports 52% Increase in Earnings Per Share On 160% Increase in Net Sales for Quarter Ended January 31, 2002; EPS - $0.32 vs. $0.21 For...
Cantel Medical Reports Record Results; Income From Continuing Operations Increases 43% for Quarter and 72% for Year Ended July 31, 2002.
Cantel Medical Reports 65% Increase in Net Income On 34% Increase in Net Sales for Quarter Ended October 31, 2002; EPS - $0.13 vs. $0.09 for Quarter.
Cantel Medical Reports Results for Quarter Ended January 31, 2003; EPS - $0.24 vs. $0.21 for Quarter $0.37 vs. $0.30 for Six Months.
Cantel Medical Reports Results for Quarter Ended April 30, 2003; EPS - $0.23 Vs. $0.23 For Quarter; $0.60 Vs. $0.54 For Nine Months.
Cantel Medical Reports Net Income up 39% on 43% Increase in Net Sales for Quarter Ended April 30, 2004; EPS - $0.30 vs. $0.23 for Quarter; $0.74 vs....
Cantel Medical Reports Results for Quarter Ended April 30, 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles